Publication | Closed Access

Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial

OncologyAdvanced Lung DiseaseDocetaxel Versus DocetaxelClinical TrialsPathologyBronchial NeoplasmParallel GroupCancer TreatmentMedicineRadiation OncologyLung CancerPhase 3Health Sciences